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1. Introduction
  Over the past decade leptospirosis remains endemic 
in Sri Lanka with outbreaks once every four to five 
years. Beginning from the latter part of the year 2007, Sri 
Lanka experienced the largest ever recorded outbreak of 
leptospirosis. The incidence of leptospirosis in Sri Lanka in 
2008 was 35.7 per 100 000 population.  Many infections are 
asymptomatic or pass off as a mild febrile episode. However, 
a small proportion develops a severe form of the disease 
with multiple organ dysfunction. Weil’s disease, the most 
severe form of leptospirosis, is characterized by jaundice, 
hemorrhage and renal failure. Pulmonary haemorrhage, 
myocarditis, meningitis and multiorgan failure are known 
complications, with an overall mortality rate of 5%-15%[1]. 
Ten percent of ICU admissions in Sri Lanka in 2007 were 
due to leptospirosis and 65% of these patients died due to 
complications of leptospirosis[2]. 
  Endothelial dysfunction is considered one of the 
mechanisms by which organ damage takes place in severe 
leptospirosis[3,4]. Nitric oxide (NO) is considered to be an 
important mediator of endothelial dysfunction in sepsis. 
Pro-inflammatory cytokines such as interleukins 1 and 6, 
and tumour necrosis factor alpha are known to increase the 
expression of inducible endothelial nitric oxide synthase 
(iNOS), leading to increased levels of NO in sepsis[5]. 
The clinical manifestations of severe sepsis and severe 
leptospirosis are similar, however little is known of the 
similarities in pathogenesis between the two conditions. 
Nonetheless, leptospirosis is known to stimulate the 
production of pro-inflammatory cytokines[6] which could 
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result in elevated NO levels[7]. High serum nitrate and 
nitrite levels have been previously demonstrated in severe 
leptospirosis[8].  Expression of iNOS and NO has been shown 
to have important roles in eliminating the leptospires[9] as 
well as leading to severe pathology[10].
  The aim of this prospective case control study was to 
determine whether serum nitrite levels are significantly 
elevated in patients with leptospirosis compared to healthy 
controls. 
2. Materials and methods
  The study was conducted in three centres in Sri Lanka– 
the Colombo North Teaching Hospital (Ragama), Base 
Hospital (Gampaha) and Base Hospital (Homagama). Ethics 
approval was obtained from the Ethics Review Committee of 
the Faculty of Medicine, Colombo. 
  Patients with fever, myalgia, and conjunctival injection, 
with a history of working in paddy fields or other contact 
areas of rat infestation, presenting within 7 days of onset 
of symptoms were recruited for the study over a period 
of approximately 3 months, i.e., from 31st June to 3rd 
September 2009. After the initial assessment for eligibility 
criteria, the cases were screened using a symptom 
checklist and questionnaire to diagnose leptospirosis 
according to the leptospirosis case definition. The 
surveillance case definition for diagnosis of leptospirosis 
published by the Epidemiology Unit of the Ministry of 
Health Sri Lanka in 2005 was used for this study[11]. 
Diagnosis was confirmed by the microagglutination test 
(MAT) with the following criteria: those with a titre ≥400, 
along with those seroconverting to a titre of ≥200[12,13]. 
Demographic data and clinical data were obtained from the 
patients themselves whilst results of investigations done 
were obtained from patient records.
  Patients without complications were followed-up for 
two weeks or until they were discharged from hospital. 
Patients who developed complications/severe disease 
were followed-up until discharge/death in the respective 
hospitals.
  Out of the 20 in whom the first MAT test was performed, 
thirteen patients were sampled for a repeat MAT 
approximately 3 weeks from the onset of illness. Thirteen 
age, sex matched healthy individuals who tested MAT 
negative were taken as control subjects. Informed written 
consent was obtained from patients prior to sampling.  A 
total of 4 mL of blood was collected from each patient, 2 mL 
for the determination of nitrite levels and the other 2 mL 
for the MAT test.  Sera were separated and frozen at -20 曟. 
MAT tests were performed at the Medical Research Institute 
(MRI), Colombo, Sri Lanka. 
  Serum nitrite levels were measured in these patients 
and age, sex matched healthy controls using the Griess 
method[14]. The serum samples were first thawed then 
deproteinized by adding Zinc Sulfate.  Deproteinization 
is a necessary step in the measurement of serum nitrite 
concentrations[15]. Twenty microliters of 300 mg/mL Zinc 
sulphate solution was added to 400 毺L of serum, vortexed 
for 1 minute, and centrifuged at 10 000 g for 10 minutes at 
room temperature. The supernatant was pipetted out and 
centrifuged again for 8 minutes. The clear supernatant was 
distributed equally (100 毺L each) amongst 3 wells in the 
96 well ELISA plate. An equal volume of 5% phosphoric 
acid was added to the first well, to determine the reading 
obtained by the background colour of the serum and an 
equal volume of Griess reagent (equal mixture of 1% 
Sulphanilamide in 5% phosphoric acid and 0.1% N-(1-
naphthyl) ethylenediamine hydrochloride in distilled water) 
was added to the second and third wells. The plates were 
kept for 15 minutes at room temperature and the optical 
density was measured at 540 nm
using the ELISA reader (Bio-Tek Instruments INC, USA).  A 
dilution series (0.193, 0.391, 0.781, 1.56, 3.125, 6.25, 12.5, 
25, 50 and 100 毺M) of NaNO2 was prepared from 100 毺M 
NaNO2 solution using distilled water. Each dilution (100 毺L)
was mixed with an equal volume of Griess reagent and the 
optical density was measured at 540 nm. A standard curve 
was plotted against optical density and NaNO2 concentration. 
For each serum, OD reading of the Griess reaction was 
corrected by subtracting the OD value of the phosphoric 
acid control.  The amount of nitrite in the human serum was 
calculated using this standard curve for NaNO2.
  Statistical analysis was performed using SPSS version 
16.0. Data was analyzed to determine if a correlation 
existed between nitrite levels and hematological indices 
and reciprocal MAT titre using Pearson’s correlation. The 
nitrite levels were compared between the patient group and 
the control group using the Student t test. The reciprocal 
MAT titre was compared to the day of illness (Spearman’s 
correlation). Statistical significance defined as P<0.05 was 
evaluated using the Student t test. 
3. Results
  Twenty of the 75 patients tested were diagnosed as having 
leptospirosis. Because of the high prevalence of other 
infectious disease in the patient population from which the 
sample was drawn, a MAT results cut off titre of 400 together 
with patients seroconverting to 200 or more were selected as 
this would give a higher specificity for leptospirosis. Of the 
18 controls, 4 had positive MAT titres of 100 for leptospirosis, 
and one patient had an overt abscess; these were excluded. 
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Thus, thirteen controls were included in the final analysis. 
There was a significant positive correlation between the MAT 
titre and the day of illness (r = 0.547; P<0.0001)(Figure 1).
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Figure 1. Association between MAT titer and day of illness. (r = 
0.547; P<0.0001 Spearmann correlation, n=61).
3.1. Serum nitrite levels                
  The standard curve obtained with a dilution series 
of NaNO2 is shown in Figure 2. Serum nitrite levels of 
patients and controls were calculated as described 
above.  According to the standard curve used for the 
calculation of nitrite levels, the lowest detectable 
value was 0.193毺M; therefore levels falling below 
this were assigned this value. The values ranged from 
0.193 to 1.00 毺M, and the mean value was 0.359 毺M.
This was statistically, significantly higher compared to the 
nitrite levels in the control group (P = 0.014 ) (Figure 3).   
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Figure 2. The standard curve for NaNO2.
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Figure 3. Nitrite levels in patients and controls. 
[Controls (n=13): (0.216依0.051)毺M; mean依SD]; Patients (n=20): 
0.193 to 1.00 毺M, mean 0.359 毺M, P<0.014. 
3.2. Correlation of nitrite values with disease parameters. 
  Nitrtite levels were correlated with haematological indices 
(white blood cell count, neutrophil count, lowest platelet 
count) and MAT, but there was no significant correlation. 
The sample size was inadequate to compare nitrite levels 
with clinical outcome, severity, or the occurrence of organ 
dysfunction.
4. Discussion
  The main aim of this study was to see whether blood nitrite 
levels are increased in patients with leptospirosis. Our study 
showed that serum nitrite levels are increased in patients 
with confirmed leptospirosis compared to healthy controls. 
This finding is in keeping with previous studies[8].  Elevated 
serum nitrite levels have been reported in other infectious 
diseases such as dengue[16] and malaria[17]. It is possible that 
elevated serum nitrite levels reflect a non-specific response 
to certain infections; nonetheless the demonstration of 
elevated serum nitrite levels in leptospirosis supports the 
hypothesis that endothelial dysfunction plays a role in the 
pathogenesis of the disease. 
  The need for predictors of mortality and morbidity in 
leptospirosis has been highlighted[18]. Novel Biomarkers 
such as Copeptin and Pentraxin have been investigated 
as potential predictors of severity in leptospirosis[19-21].
Serum nitrite levels may be one of the potential biomarkers 
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of severity in leptospirosis although our small sample size 
precluded such analysis. Total NO levels, i.e., nitrate and 
nitrite together, may be a better indicator of endothelial 
dysfunction and severity than nitrite alone, and we suggest 
the need for further studies in this area. 
 Limitations of our study included small sample size and the 
difficulty in differentiating other infectious diseases with 
similar clinical syndromes when identifying the cases. For 
logistic reason and due to economic constrains, serology  for 
other infectious disease could not be performed on the 20 
patients included in our sample. Another potential limitation 
is that only male patients were enrolled in our study.  
  In conclusion, patients with leptospirosis have higher 
serum nitrite levels compared to matched controls.  We were 
unable to demonstrate a correlation between nitrite levels 
and markers of disease severity due to small sample size. 
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